FDA’s New AI Tool Cuts Review Time From 3 Days To 6 Minutes

Ron Schmelzer, Contributor, Ron Schmelzer, Contributor https://www.forbes.com/sites/ronschmelzer/

The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, several weeks ahead of its original schedule.